-
Product Name
TAF9B antibody
- Documents
-
Description
TAF9B Rabbit Polyclonal antibody. Positive IP detected in HeLa cells. Positive IHC detected in human breast cancer tissue.
-
Tested applications
ELISA, IHC, IP
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
DN 7 antibody; DN7 antibody; TAF9B antibody; TAF9L antibody; TAFII31L antibody; TFIID 31 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of TAF9B recombinant protein (Accession Number: NM_015975). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
IP: 1:200-1:1000
IHC: 1:20-1:200
-
Validations
Immunohistochemical of paraffin-embedded human breast cancer using Catalog No:115991(TAF9B antibody) at dilution of 1:100 (under 10x lens)
IP Result of anti-TAF9B (IP:Catalog No:115991, 4ug; Detection:Catalog No:115991 1:300) with HeLa cells lysate 4000ug.
-
Background
Transcription initiation factor TFIID subunit 9B (TAF9B), also names neuronal cell death-related protein 7,transcription initiation factor TFIID subunit 9-like,transcription-associated factor TAFII31L. It is essential for cell viability. TAF9 and TAF9B are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. May have a role in gene regulation associated with apoptosis. TAFs are components of the transcription factor IID (TFIID) complex, the TBP-free TAFII complex (TFTC), the PCAF histone acetylase complex and the STAGA transcription coactivator-HAT complex. TFIID or TFTC are essential for the regulation of RNA polymerase II-mediated transcription.It's molecular mass is 31kd.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"